Ardelyx, Inc. (ARDX)
6.14
+0.03
(+0.49%)
USD |
NASDAQ |
May 19, 14:22
Ardelyx Research and Development Expense (Quarterly) : 19.27M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 1.719B |
| PTC Therapeutics, Inc. | 100.87M |
| Syndax Pharmaceuticals, Inc. | 58.84M |
| Akebia Therapeutics, Inc. | 14.48M |
| ACADIA Pharmaceuticals, Inc. | 76.87M |